Home › Research › Risk factors
Morinda officinalis How. - A comprehensive review of traditional uses, phytochemistry and pharmacology
Zhang JH, Xin HL, Xu YM, Shen Y, He YQ, Hsien-Yeh, Lin B, Song HT et al.. Journal of ethnopharmacology, 2017-11-07
Topic: Risk, prevention and care in population studies
Plain-language summary
Results The literature supported the ethnomedicinal uses of MO as recorded in China for various purposes. Pharmacokinetic studies have demonstrated that the main components of MO including monotropein and deacetyl asperulosidic acid are distributed in various organs and tissues. The investigation on acute toxicity and genotoxicity indicated that MO is nontoxic. There have no reports on significant adverse effect at a normal dose in clinical application, but MO at dose of more than 1000mg/kg may cause irritability, insomnia and unpleasant sensations in individual cases.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Zhang, J. H., Xin, H. L., Xu, Y. M., Shen, Y., He, Y. Q., Hsien-Yeh, et al. (2018). Morinda officinalis How. - A comprehensive review of traditional uses, phytochemistry and pharmacology. Journal of ethnopharmacology. https://doi.org/10.1016/j.jep.2017.10.028
Vancouver
Zhang JH, Xin HL, Xu YM, Shen Y, He YQ, Hsien-Yeh, et al. Morinda officinalis How. - A comprehensive review of traditional uses, phytochemistry and pharmacology. Journal of ethnopharmacology. 2018. doi:10.1016/j.jep.2017.10.028. PMID: 29126988.
BibTeX
@article{zhang2018-29126988,
author = {Zhang, J. H. and Xin, H. L. and Xu, Y. M. and Shen, Y. and He, Y. Q. and Hsien-Yeh and Lin, B. and Song, H. T. and others},
title = {{Morinda officinalis How. - A comprehensive review of traditional uses, phytochemistry and pharmacology}},
journal = {Journal of ethnopharmacology},
year = {2018},
doi = {10.1016/j.jep.2017.10.028},
pmid = {29126988},
url = {https://doi.org/10.1016/j.jep.2017.10.028}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Results The literature supported the ethnomedicinal uses of MO as recorded in China for various purposes.
- Pharmacokinetic studies have demonstrated that the main components of MO including monotropein and deacetyl asperulosidic acid are distributed in various organs and tissues.
- The investigation on acute toxicity and genotoxicity indicated that MO is nontoxic.
- There have no reports on significant adverse effect at a normal dose in clinical application, but MO at dose of more than 1000mg/kg may cause irritability, insomnia and unpleasant sensations in individual cases.
New to this subject? Start with our plain-English guide: Risk factors, ranked →
Study details
- Evidence strengthLow
How this study scored 38/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multicenter collaboration, so those were left out: it earned 22 of the 58 points we could judge it on, which is 38 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Journal of ethnopharmacology) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 2 / 5 | 2018 — within 10 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 29126988) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 22 / 58 | Scored on 11 of 20 parts. We have no data for the rest, so they are left out: 22 of the 58 points we could judge it on is 38 out of 100. |
| Total | 38 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.